Charyguly Annageldiyev

Oncology
500 University Dr
Hershey, PA 17033

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications

High-grade follicular B-cell lymphoma-associated C3 rapidly progressive glomerulonephritis: a rare association.

High-grade follicular B-cell lymphoma-associated C3 rapidly progressive glomerulonephritis: a rare association.

Journal: BMJ case reports
Published: March 16, 2026

Analyzing Real-World Infection Risk in Multiple Myeloma Patients Receiving Teclistamab.

Analyzing Real-World Infection Risk in Multiple Myeloma Patients Receiving Teclistamab.

Journal: Current oncology (Toronto, Ont.)
Published: January 10, 2026

Pharmacological blockade of rho kinase enhances venetoclax responses in translational models of acute myeloid leukemia.

Pharmacological blockade of rho kinase enhances venetoclax responses in translational models of acute myeloid leukemia.

Journal: Haematologica
Published: August 25, 2025

Cytotoxic lymphocytes induced by engineered human dendritic cells mediate potent anti-leukemia activity.

Cytotoxic lymphocytes induced by engineered human dendritic cells mediate potent anti-leukemia activity.

Journal: Cancer immunology, immunotherapy : CII
Published: September 22, 2024

Critical roles of IKAROS and HDAC1 in regulation of heterochromatin and tumor suppression in T-cell acute lymphoblastic leukemia.

Critical roles of IKAROS and HDAC1 in regulation of heterochromatin and tumor suppression in T-cell acute lymphoblastic leukemia.

Journal: Leukemia
Published: May 22, 2024

CD26lowPD-1+ CD8 T cells are terminally exhausted and associated with leukemia progression in acute myeloid leukemia.

CD26lowPD-1+ CD8 T cells are terminally exhausted and associated with leukemia progression in acute myeloid leukemia.

Journal: Frontiers in immunology
Published: February 18, 2023

Activation of GPR44 decreases severity of myeloid leukemia via specific targeting of leukemia initiating stem cells.

Activation of GPR44 decreases severity of myeloid leukemia via specific targeting of leukemia initiating stem cells.

Journal: Cell reports
Published: July 22, 2022

DJ4 Targets the Rho-Associated Protein Kinase Pathway and Attenuates Disease Progression in Preclinical Murine Models of Acute Myeloid Leukemia.

DJ4 Targets the Rho-Associated Protein Kinase Pathway and Attenuates Disease Progression in Preclinical Murine Models of Acute Myeloid Leukemia.

Journal: Cancers
Published: August 12, 2021

The PI3K/AKT Pathway Inhibitor ISC-4 Induces Apoptosis and Inhibits Growth of Leukemia in Preclinical Models of Acute Myeloid Leukemia.

The PI3K/AKT Pathway Inhibitor ISC-4 Induces Apoptosis and Inhibits Growth of Leukemia in Preclinical Models of Acute Myeloid Leukemia.

Journal: Frontiers in oncology
Published: November 11, 2019

Glucocorticoids enhance the antileukemic activity of FLT3 inhibitors in FLT3-mutant acute myeloid leukemia.

Glucocorticoids enhance the antileukemic activity of FLT3 inhibitors in FLT3-mutant acute myeloid leukemia.

Journal: Blood
Published: August 28, 2019

Ceramide Analogue SACLAC Modulates Sphingolipid Levels and MCL-1 Splicing to Induce Apoptosis in Acute Myeloid Leukemia.

Ceramide Analogue SACLAC Modulates Sphingolipid Levels and MCL-1 Splicing to Induce Apoptosis in Acute Myeloid Leukemia.

Journal: Molecular cancer research : MCR
Published: June 11, 2019

Downregulation of CD73 associates with T cell exhaustion in AML patients.

Downregulation of CD73 associates with T cell exhaustion in AML patients.

Journal: Journal of hematology & oncology
Published: February 11, 2019
Showing 1-12 of 14

Last Updated: 09/26/2026